ALNY
NASDAQStockAlnylam Pharmaceuticals, Inc.
$313.45-3.77 (-1.19%)
52-Week Range
$224.32
$491.22
Key Stats
Market Cap
41.6B
P/E Ratio
155.95
Dividend Yield
—
Beta
0.38
Volume
526.0K
Avg Volume
1.5M
Performance
1M
+2.84%
3M
-18.97%
6M
-31.21%
YTD
-20.73%
1Y
+31.22%
3Y
+70.78%
5Y
+117.10%
Price Chart
ETF Exposure
ALNY is held by 460 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SUAS.L | iShares MSCI USA SRI UCITS ETF | 0.32% |
| SUUS.L | iShares MSCI USA SRI UCITS ETF | 0.32% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.32% |
| REMC | Columbia Research Enhanced Mid Cap ETF | 0.32% |
| HEQQ | JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF | 0.32% |
| IWR | iShares Russell Mid-Cap ETF | 0.32% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 0.32% |
| XMVU.SG | Xtrackers MSCI USA Minimum Volatility UCITS ETF 1D | 0.32% |
| XMU.TO | iShares MSCI Min Vol USA Index ETF | 0.32% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.30% |
| IMCB | iShares Morningstar Mid-Cap ETF | 0.30% |
| JKG | iShares Morningstar Mid-Cap ETF | 0.30% |
| HQGO | Hartford US Quality Growth ETF | 0.29% |
| XFVT.L | Xtrackers Vietnam Swap UCITS ETF 1C | 0.29% |
| QGRW | WisdomTree U.S. Quality Growth Fund | 0.29% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.28% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.28% |
| JEPQ | JPMorgan Nasdaq Equity Premium Income ETF | 0.27% |
| PTNQ | Pacer Trendpilot 100 ETF | 0.26% |
| ROUS | Hartford Multifactor US Equity ETF | 0.26% |
| MODL | VictoryShares WestEnd U.S. Sector ETF | 0.25% |
| XMUD.L | Xtrackers MSCI USA Swap UCITS ETF 1C | 0.25% |
| XMUS.L | Xtrackers MSCI USA Swap UCITS ETF 1C | 0.25% |
| CGGO | Capital Group Global Growth Equity ETF | 0.25% |
| JMOM | JPMorgan U.S. Momentum Factor ETF | 0.25% |
| 500.PA | Amundi S&P 500 Swap UCITS ETF EUR Acc | 0.24% |
| XT | iShares Future Exponential Technologies ETF | 0.24% |
| CLSE | Convergence Long/Short Equity ETF | 0.24% |
| QCLR | Global X - Nasdaq 100 Collar 95-110 ETF | 0.24% |
| NULC | Nuveen ESG Large-Cap | 0.23% |
| QTR | Global X - Nasdaq 100 Tail Risk ETF | 0.23% |
| QRMI | Global X - Nasdaq 100 Risk Managed Income ETF | 0.23% |
| QYLG | Global X - Nasdaq 100 Covered Call & Growth ETF | 0.23% |
| QDVC.DE | iShares MSCI USA Mid-Cap Equal Weight UCITS ETF | 0.23% |
| CNDX.L | iShares NASDAQ 100 UCITS ETF | 0.23% |
| CNX1.L | iShares NASDAQ 100 UCITS ETF | 0.23% |
| CSNDX.SW | iShares NASDAQ 100 UCITS ETF | 0.23% |
| GPIQ | Goldman Sachs Nasdaq-100 Premium Income ETF | 0.23% |
| SXRV.DE | iShares NASDAQ 100 UCITS ETF | 0.23% |
| EQQD.L | Invesco NASDAQ-100 Swap UCITS ETF | 0.23% |
| EQQS.L | Invesco NASDAQ-100 Swap UCITS ETF | 0.23% |
| QQQ | Invesco QQQ Trust, Series 1 | 0.23% |
| QQQM | Invesco NASDAQ 100 ETF | 0.23% |
| XNAS.F | Xtrackers NASDAQ 100 UCITS ETF 1C | 0.23% |
| XNAS.L | Xtrackers NASDAQ 100 UCITS ETF 1C | 0.23% |
| EQEU.DE | Invesco EQQQ NASDAQ-100 UCITS ETF (EUR Hdg) | 0.23% |
| EQGB.SW | Invesco EQQQ Nasdaq-100 UCITS ETF | 0.23% |
| EQQQ.DE | Invesco EQQQ Nasdaq-100 UCITS ETF | 0.23% |
| EQQQ.L | Invesco EQQQ Nasdaq-100 UCITS ETF | 0.23% |
| EQQU.L | Invesco EQQQ Nasdaq-100 UCITS ETF | 0.23% |
About ALNY ETF Exposure
Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.